News for CanSino Biologics Inc. (CJH.F)

A botched deal last year between Canada and Chinese vaccine manufacturer CanSino Biologics Inc. laid bare this country’s vulnerabilities amid efforts to devise a proper immunization plan.

When the Trudeau government spent big to pre-order vaccines, it said Canada would be well prepared. But now, Canadian inoculation rates are behind peer nations, as experts say federal officials put too much faith in global supply chains

The first batch of 2 million vaccines from China's CanSino Biologics Inc , produced in Mexico, will be ready in the second half of March, the company said on Sunday. Mexico in early February received its first shipment of the active ingredient for the shot, which is being packaged in Queretaro state by Mexican firm Drugmex, CanSino said in a statement. Mexico has so far received Pfizer, AstraZeneca, Sputnik V and Sinovac vaccines.

The first batch of 2 million vaccines from China's CanSino Biologics Inc, produced in Mexico, will be ready in the second half of March, the company said on Sunday. Mexico in early... | February 28, 2021

CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine in China 2021-02 Tianjin, February 25, 2021- CanSino Biologics Inc. announced that... | February 27, 2021

HANGZHOU, China, Feb. 26, 2021 /PRNewswire/ -- China National Medical Products Administration (NMPA) announced on February 25 to grant conditional...

/PRNewswire/ -- China National Medical Products Administration (NMPA) announced on February 25 to grant conditional marketing authorization of Recombinant...

India’s huge capacity to make coronavirus vaccines is helping the country take on China in the battle to gain political influence across the developing world

Read more about China approves 2 more domestic Covid-19 vaccines, increasing number to 4 on Business Standard. The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm)